Scancell, a UK based company developing anti-glycan antibodies, have today announced an agreement with mAbsolve to license our STR technology for Fc silencing. Full details available in the press release below.
Scancell, a UK based company developing anti-glycan antibodies, have today announced an agreement with mAbsolve to license our STR technology for Fc silencing. Full details available in the press release below.